GW pharms may own the rights on treating glioma with cannabis oil exclusivity until June 2029. Thoughts? -Lincoln GW Pharmaceuticals plc Announces US Patent Allowance for Use of Cannabinoids in Treating Glioma The subject patent specifically covers a method for treating glioma in a human using a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) wherein the cannabinoids are in a ratio of from 1:1 to 1:20 (THC:CBD) with the intent to reduce cell viability, inhibit cell growth or reduce tumor volume. A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application. The issued patent from this application will provide an exclusivity period until June 2029. gwpharm/GW%20Pharmaceuticals%20plc%20Announces%20US%20Patent%20Allowance%20for%20Use%20of%20Cannabinoids%20in%20Treating%20Glioma.aspx
Posted on: Sun, 04 May 2014 19:16:18 +0000
Trending Topics
Recently Viewed Topics
© 2015